ZYME
Zymeworks Inc.
$15.23
+$0.04(+0.26%)
47
Overall
--
Value
50
Tech
44
Quality
Market Cap
$1.05B
Volume
386.41K
52W Range
$9.03 - $17.70
Target Price
$21.05
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | -- | $29.5M | $39.0M | $26.7M | $412.5M | $76.0M | $76.3M | ||
| Total Revenue | -- | $29.5M | $39.0M | $26.7M | $412.5M | $76.0M | $76.3M | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | $56.9M | $115.9M | -- | -- | -- | -- | -- | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $-56.9M | $29.5M | $39.0M | $26.7M | $412.5M | $76.0M | $76.3M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $29.5M | $180.1M | $226.4M | $242.3M | $282.0M | $214.1M | $213.4M | ||
| Research & Development | $56.7M | $115.9M | $171.2M | $199.8M | $208.6M | $143.6M | $151.9M | ||
| Research Expense | $56.7M | $115.9M | $171.2M | $199.8M | $208.6M | $143.6M | $134.6M | ||
| Selling, General & Administrative | $29.5M | $64.2M | $55.2M | $42.6M | $73.4M | $70.4M | $61.5M | ||
| General & Administrative Expenses | $29.5M | $64.2M | $55.2M | $42.6M | $73.4M | $70.4M | $61.5M | ||
| Salaries & Wages | $-5.2K | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-1.9M | $2.3M | $3.4M | $3.7M | $6.2M | $7.5M | $4.2M | ||
| Depreciation & Amortization | $-1.9M | $2.3M | $3.4M | $3.7M | $6.2M | $7.5M | $4.2M | ||
| Amortization | $-1.8M | $3.1M | $4.2M | $2.8M | $1.0M | $2.7M | $4.5M | ||
| Other Operating Expenses | $-530.0K | $-2.4M | -- | -- | -- | $-14.0K | $-38.0K | ||
| OPERATING INCOME | |||||||||
| Operating income | $-86.4M | $-151.3M | $-187.5M | $-215.6M | $130.5M | $-138.1M | $-137.1M | ||
| EBITDA | $-30.8M | $-138.7M | $-177.2M | $-206.1M | $147.2M | $-101.9M | $-105.4M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | $166.0K | -- | -- | -- | -- | -- | -- | ||
| Intinc | $2.6M | $5.9M | $5.7M | $2.0M | $3.6M | $19.7M | $19.9M | ||
| Net Non-Operating Interest Income/Expense | $2.6M | $5.9M | $5.7M | $2.0M | $3.6M | $19.7M | $19.9M | ||
| Other Income/Expense | $-49.4M | $1.4M | $-1.6M | $-1.3M | $1.1M | $894.0K | $-558.0K | ||
| Other Special Charges | $49.4M | $-595.0K | $1.6M | $1.3M | $1.1M | $-894.0K | $558.0K | ||
| SPECIAL ITEMS | |||||||||
| Other Impairment Of Capital Assets | -- | $768.0K | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-34.4M | $-146.0M | $-187.5M | $-215.7M | $135.2M | $-119.2M | $-116.6M | ||
| Pre-Tax Income | $-34.4M | $-146.0M | $-180.1M | $-212.4M | $135.2M | $-119.2M | $-116.6M | ||
| INCOME TAX | |||||||||
| Tax Provision | $2.2M | $-582.0K | $429.0K | $-516.0K | $10.9M | $-568.0K | $6.1M | ||
| NET INCOME | |||||||||
| Net Income | $-36.6M | $-145.4M | $-180.6M | $-211.8M | $124.3M | $-118.7M | $-122.7M | ||
| Net Income (Continuing Operations) | $-36.6M | $-145.4M | $-180.6M | $-211.8M | $124.3M | $-118.7M | $-122.7M | ||
| Net Income (Discontinued Operations) | $-36.6M | $-145.4M | $-180.6M | $-211.8M | $124.3M | $-118.7M | $-122.7M | ||
| Net Income (Common Stockholders) | $-36.6M | $-145.4M | $-180.6M | $-211.8M | $124.3M | $-118.7M | $-122.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-117.3M | ||
| TOTALS | |||||||||
| Total Expenses | $86.4M | $180.1M | $226.4M | $242.3M | $282.0M | $214.1M | $213.4M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $29.1M | $38.0M | $50.4M | $51.6M | $65.2M | $68.9M | $75.8M | ||
| Average Shares Outstanding (Diluted) | $29.1M | $38.0M | -- | $52.1M | $65.2M | $68.9M | $75.9M | ||
| Shares Outstanding | $32.0M | $45.5M | $46.1M | $57.7M | $64.0M | $70.6M | $69.6M | ||
| Basic EPS | $-1.26 | $-3.83 | $-3.58 | $-4.11 | $1.91 | $-1.72 | $-1.62 | ||
| Basic EPS (Continuing Operations) | $-1.26 | $-3.83 | $-3.58 | $-4.11 | $1.91 | $-1.72 | $-1.62 | ||
| Diluted EPS | $-1.26 | $-3.83 | $-3.58 | $-4.61 | $1.9 | $-1.72 | $-1.62 | ||
| Diluted EPS (Continuing Operations) | $-1.26 | $-3.83 | -- | $-4.61 | $1.9 | $-1.72 | $-1.62 | ||
| OTHER METRICS | |||||||||
| Development Expense | -- | -- | -- | -- | -- | -- | $17.3M | ||
| Other Gand A | $29.5M | $64.2M | $55.2M | $42.6M | $73.4M | $70.4M | $61.5M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZYME | $15.23 | +0.3% | 386.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |